Tracers / [211At]At-211-AMT

[211At]At-211-AMT

Also written as At-211-AMT

Radionuclide: At-211 t½ 431 min
Modality: Therapy
Production route: —
Stage: —
Syntheses indexed: 2

What it is

Compound class: —
Target / mechanism: —
Clinical application: —
Theranostic pair: <a href="/tracers/c11-amt/">c11-amt</a>

Regulatory status

FDA: —
EMA (centralised): —
Other approvals: —
Brand names: —

Clinical use

Typical injected activity: —
Uptake time: —

Reported in the literature. Not a dosing recommendation.

Published syntheses

Module	Cassette	Purification	Yield %	RCP %	Precursor / supplier	Source
—	—	—	—	—	stannyl precursor	32916470 2020 Nucl Med Biol
—	—	—	—	—	—	3352274 1988 J Surg Oncol

Need this precursor?We can point you to suppliers for [211At]At-211-AMT, or handle the enquiry for you.

Get in touch

Notes

Added at stage 21 from therapy-discovered.xlsx (bulk PubMed search by isotope/therapy-type/known-agent, not individually researched yet) -- 1 articles found. Target/mechanism, clinical application, indications, approval and precursor fields still need per-agent research and are intentionally left empty. Diagnostic pair signal at discovery: YES - C-11.